FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2575085548> ?p ?o ?g. }

• W2575085548 endingPage "345" @default.
• W2575085548 startingPage "334" @default.
• W2575085548 abstract "Patients with B‐cell hematologic malignancies who progress through first‐ or second‐line chemotherapy have a poor prognosis. Early clinical trials with autologous anti‐ CD 19 chimeric antigen receptor ( CAR ) T cells have demonstrated promising results for patients who have relapsed or refractory disease. Lymphodepleting conditioning regimens, including cyclophosphamide, fludarabine, pentostatin, bendamustine, interleukin‐2, and total body irradiation, are often administered before the infusion of CAR T cells, allowing for greater T‐cell expansion. The major toxicity associated with CAR T‐cell infusions is cytokine release syndrome ( CRS ), a potentially life‐threatening systemic inflammatory disorder. The quick onset and progression of CRS require rapid detection and intervention to reduce treatment‐related mortality. Management with tocilizumab can help ameliorate the symptoms of severe CRS , allowing steroids, which diminish the expansion and persistence of CAR T cells, to be reserved for tocilizumab‐refractory patients. Other toxicities of CAR T‐cell therapy include neutropenia and/or febrile neutropenia, infection, tumor lysis syndrome, neurotoxicity and nausea/vomiting. A review of patients’ medications is imperative to eliminate medications that may contribute to treatment‐related toxicities. Studies are ongoing to help optimize patient selection, preparation, safety, and management of individuals receiving CAR T cells. Long‐term follow‐up will help establish the place of CAR T cells in therapy." @default.
• W2575085548 created "2017-01-26" @default.
• W2575085548 creator A5029755243 @default.
• W2575085548 creator A5045132841 @default.
• W2575085548 creator A5062191058 @default.
• W2575085548 creator A5064752432 @default.
• W2575085548 creator A5072346200 @default.
• W2575085548 creator A5078831303 @default.
• W2575085548 date "2017-02-22" @default.
• W2575085548 modified "2023-10-15" @default.
• W2575085548 title "Chimeric Antigen Receptor T Cells in Hematologic Malignancies" @default.
• W2575085548 cites W1555553634 @default.
• W2575085548 cites W1556687169 @default.
• W2575085548 cites W1647507681 @default.
• W2575085548 cites W1964173702 @default.
• W2575085548 cites W1964809183 @default.
• W2575085548 cites W1967517831 @default.
• W2575085548 cites W1979099665 @default.
• W2575085548 cites W1985579610 @default.
• W2575085548 cites W1991890073 @default.
• W2575085548 cites W1994594038 @default.
• W2575085548 cites W1996815863 @default.
• W2575085548 cites W2003696220 @default.
• W2575085548 cites W2004919491 @default.
• W2575085548 cites W2010611999 @default.
• W2575085548 cites W2038426832 @default.
• W2575085548 cites W2040414203 @default.
• W2575085548 cites W2045475405 @default.
• W2575085548 cites W2047203592 @default.
• W2575085548 cites W2047205338 @default.
• W2575085548 cites W2051549641 @default.
• W2575085548 cites W2076560655 @default.
• W2575085548 cites W2077994554 @default.
• W2575085548 cites W2082708772 @default.
• W2575085548 cites W2099570622 @default.
• W2575085548 cites W2105400883 @default.
• W2575085548 cites W2118796952 @default.
• W2575085548 cites W2124373740 @default.
• W2575085548 cites W2127734125 @default.
• W2575085548 cites W2129702476 @default.
• W2575085548 cites W2130011407 @default.
• W2575085548 cites W2130338247 @default.
• W2575085548 cites W2137804513 @default.
• W2575085548 cites W2146059841 @default.
• W2575085548 cites W2157258473 @default.
• W2575085548 cites W2164364292 @default.
• W2575085548 cites W2169000897 @default.
• W2575085548 cites W2170513194 @default.
• W2575085548 cites W2217873455 @default.
• W2575085548 cites W2239147471 @default.
• W2575085548 cites W2265134611 @default.
• W2575085548 cites W2302851559 @default.
• W2575085548 cites W2305384511 @default.
• W2575085548 cites W2307692446 @default.
• W2575085548 cites W2322793438 @default.
• W2575085548 cites W2342423058 @default.
• W2575085548 cites W2343125831 @default.
• W2575085548 cites W2517930087 @default.
• W2575085548 cites W2552415180 @default.
• W2575085548 cites W2564558272 @default.
• W2575085548 cites W2660626308 @default.
• W2575085548 cites W2693970509 @default.
• W2575085548 cites W2737070795 @default.
• W2575085548 cites W2764189930 @default.
• W2575085548 cites W2794874600 @default.
• W2575085548 cites W2890387988 @default.
• W2575085548 cites W2891931112 @default.
• W2575085548 cites W2892023224 @default.
• W2575085548 cites W4247087093 @default.
• W2575085548 doi "https://doi.org/10.1002/phar.1900" @default.
• W2575085548 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28079265" @default.
• W2575085548 hasPublicationYear "2017" @default.
• W2575085548 type Work @default.
• W2575085548 sameAs 2575085548 @default.
• W2575085548 citedByCount "47" @default.
• W2575085548 countsByYear W25750855482017 @default.
• W2575085548 countsByYear W25750855482018 @default.
• W2575085548 countsByYear W25750855482019 @default.
• W2575085548 countsByYear W25750855482020 @default.
• W2575085548 countsByYear W25750855482021 @default.
• W2575085548 countsByYear W25750855482022 @default.
• W2575085548 countsByYear W25750855482023 @default.
• W2575085548 crossrefType "journal-article" @default.
• W2575085548 hasAuthorship W2575085548A5029755243 @default.
• W2575085548 hasAuthorship W2575085548A5045132841 @default.
• W2575085548 hasAuthorship W2575085548A5062191058 @default.
• W2575085548 hasAuthorship W2575085548A5064752432 @default.
• W2575085548 hasAuthorship W2575085548A5072346200 @default.
• W2575085548 hasAuthorship W2575085548A5078831303 @default.
• W2575085548 hasConcept C121608353 @default.
• W2575085548 hasConcept C126322002 @default.
• W2575085548 hasConcept C143998085 @default.
• W2575085548 hasConcept C203014093 @default.
• W2575085548 hasConcept C2776694085 @default.
• W2575085548 hasConcept C2776755627 @default.
• W2575085548 hasConcept C2777063308 @default.
• W2575085548 hasConcept C2777178219 @default.
• W2575085548 hasConcept C2777701055 @default.

• next